Allena Pharmaceuticals Executives
Discussion of Allena Pharmaceuticals' management performance can provide insight into the enterprise performance.
Allena |
Symbol | ALNAQ |
Name | Allena Pharmaceuticals |
Type | Pink Sheet |
Country | United States |
Exchange | PINK |
Information on Allena Pharmaceuticals Leadership is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Thematic Opportunities
Explore Investment Opportunities
Allena Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (1.0664) % which means that it has lost $1.0664 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (5.4102) %, meaning that it generated substantial loss on money invested by shareholders. Allena Pharmaceuticals' management efficiency ratios could be used to measure how well Allena Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Allena Pharmaceuticals Workforce Comparison
Allena Pharmaceuticals is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 504. Allena Pharmaceuticals holds roughly 12.0 in number of employees claiming about 2.38% of stocks in Biotechnology industry.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Allena Pink Sheet
If you are still planning to invest in Allena Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allena Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |